Pilulka Lekarny as (PR:PINK) — Stock Price
Pilulka Lekarny as (PR:PINK) is currently trading at Kč114.00 CZK, up 1.79% today. Over the past 52 weeks, shares have ranged between Kč100.00 and Kč190.00. This page tracks Pilulka Lekarny as's live share price on the PR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PINK market cap.
Pilulka Lekarny as (PINK) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Pilulka Lekarny as's daily closing share price and trading volume on the PR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Pilulka Lekarny as Income Statement — Revenue, Profit & Earnings by Year
Pilulka Lekarny as's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Kč1.30 Billion | Kč2.13 Billion | Kč2.45 Billion | Kč2.38 Billion | Kč1.78 Billion |
| Cost of Revenue | Kč1.19 Billion | Kč1.96 Billion | Kč2.19 Billion | Kč2.14 Billion | Kč1.58 Billion |
| Gross Profit | Kč115.11 Million | Kč169.12 Million | Kč259.60 Million | Kč237.59 Million | Kč198.18 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Total Operating Expenses | Kč1.40 Billion | Kč2.28 Billion | Kč307.27 Million | Kč251.58 Million | Kč197.13 Million |
| Operating Income | Kč-95.66 Million | Kč-146.22 Million | Kč-47.67 Million | Kč-13.99 Million | Kč1.06 Million |
| EBITDA | — | — | Kč-8.43 Million | Kč-1.11 Million | Kč-3.46 Million |
| EBIT | — | — | Kč-47.67 Million | Kč-13.99 Million | Kč1.06 Million |
| Interest Expense | Kč12.33 Million | Kč10.48 Million | Kč4.76 Million | Kč777.00K | Kč2.53 Million |
| Income Before Tax | Kč-126.38 Million | Kč-175.87 Million | Kč-64.01 Million | Kč-24.68 Million | Kč-25.09 Million |
| Income Tax Expense | — | — | Kč1.75 Million | Kč994.00K | Kč549.00K |
| Net Income | Kč-125.74 Million | Kč-174.94 Million | Kč-65.76 Million | Kč-25.67 Million | Kč-25.64 Million |
Pilulka Lekarny as Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Pilulka Lekarny as's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Kč237.34 Million | Kč439.70 Million | Kč605.96 Million | Kč589.14 Million | Kč497.98 Million |
| Total Current Assets | Kč146.12 Million | Kč279.10 Million | Kč208.98 Million | Kč229.83 Million | Kč225.64 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Kč67.45 Million | Kč129.26 Million | Kč1.10 Million | Kč2.97 Million | Kč3.23 Million |
| Inventory | Kč54.74 Million | Kč96.17 Million | Kč187.21 Million | Kč155.25 Million | Kč90.62 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | Kč0.00 | Kč0.00 | Kč170.00K | Kč997.00K | Kč1.85 Million |
| Total Liabilities | Kč334.08 Million | Kč408.99 Million | Kč467.03 Million | Kč385.04 Million | Kč279.92 Million |
| Total Current Liabilities | Kč326.95 Million | Kč396.22 Million | Kč433.64 Million | Kč348.62 Million | Kč271.10 Million |
| Long-term Debt | Kč2.40 Million | Kč3.67 Million | Kč24.80 Million | — | — |
| Net Debt | Kč38.28 Million | Kč66.16 Million | Kč-20.67 Million | Kč-71.61 Million | Kč-131.78 Million |
| Total Stockholder Equity | Kč-93.97 Million | Kč32.85 Million | Kč140.14 Million | Kč204.38 Million | Kč227.79 Million |
| Retained Earnings | Kč-552.59 Million | Kč-425.77 Million | Kč-251.09 Million | Kč-188.42 Million | Kč-164.04 Million |
Pilulka Lekarny as Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Pilulka Lekarny as generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Kč-44.99 Million | Kč-34.29 Million | Kč-38.15 Million | Kč24.67 Million | Kč7.39 Million |
| Capital Expenditures | Kč20.06 Million | Kč35.63 Million | Kč76.77 Million | Kč82.13 Million | Kč27.65 Million |
| Free Cash Flow | Kč-65.05 Million | Kč-69.92 Million | Kč-114.92 Million | Kč-57.46 Million | Kč-20.26 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | Kč4.68 Million | Kč-3.26 Million | Kč142.45 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Kč64.29 Million | Kč74.09 Million | Kč50.82 Million | Kč22.79 Million | Kč19.10 Million |
| Change in Cash | Kč6.58 Million | Kč-3.17 Million | Kč-109.69 Million | Kč-60.17 Million | Kč122.19 Million |
Pilulka Lekarny as Earnings History — EPS Actual vs. Analyst Estimates
Track Pilulka Lekarny as's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Pilulka Lekarny as.